DK0430045T3 - Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion - Google Patents

Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion

Info

Publication number
DK0430045T3
DK0430045T3 DK90122218.2T DK90122218T DK0430045T3 DK 0430045 T3 DK0430045 T3 DK 0430045T3 DK 90122218 T DK90122218 T DK 90122218T DK 0430045 T3 DK0430045 T3 DK 0430045T3
Authority
DK
Denmark
Prior art keywords
reaction
ethocopheryl
ascorbic acid
phosphate diesters
maillard
Prior art date
Application number
DK90122218.2T
Other languages
Danish (da)
English (en)
Inventor
Jun Inoue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of DK0430045T3 publication Critical patent/DK0430045T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
DK90122218.2T 1989-11-21 1990-11-20 Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion DK0430045T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1304479A JP2854631B2 (ja) 1989-11-21 1989-11-21 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤

Publications (1)

Publication Number Publication Date
DK0430045T3 true DK0430045T3 (da) 1995-07-17

Family

ID=17933520

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90122218.2T DK0430045T3 (da) 1989-11-21 1990-11-20 Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion

Country Status (8)

Country Link
EP (1) EP0430045B1 (ko)
JP (1) JP2854631B2 (ko)
KR (1) KR910009272A (ko)
AT (1) ATE121939T1 (ko)
CA (1) CA2029420C (ko)
DE (1) DE69019111T2 (ko)
DK (1) DK0430045T3 (ko)
ES (1) ES2071725T3 (ko)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05286848A (ja) * 1992-04-10 1993-11-02 Senju Pharmaceut Co Ltd 浴用剤
CA2129509A1 (en) * 1993-09-10 1995-03-11 Kazumi Ogata Pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis
US5955448A (en) * 1994-08-19 1999-09-21 Quadrant Holdings Cambridge Limited Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
GB2288732B (en) * 1994-04-13 1998-04-29 Quadrant Holdings Cambridge Pharmaceutical compositions
JP3362501B2 (ja) * 1994-04-28 2003-01-07 千寿製薬株式会社 角膜障害治療剤
JP3396953B2 (ja) * 1994-05-10 2003-04-14 千寿製薬株式会社 網膜疾患予防・治療剤
JPH07330501A (ja) 1994-06-14 1995-12-19 Senju Pharmaceut Co Ltd 肝保存剤および肝保存方法
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
CA2152693A1 (en) * 1994-08-05 1996-02-06 Kazumi Ogata Therapeutic composition for pancreatitis
US5795912A (en) * 1995-04-26 1998-08-18 Senju Pharmaceutical, Co., Ltd. Therapeutic composition for corneal impairment
CA2179940A1 (en) * 1995-07-18 1997-01-19 Kazumi Ogata Antiallergic composition comprising a phosphoric diester compound
CA2186654A1 (en) * 1995-10-13 1997-04-14 Masayuki Nakamura Phosphoric diester
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
EP1053749A4 (en) * 1998-02-03 2003-01-15 Senju Pharma Co PREVENTION AND MEDICINE FOR NEURODEGENERATIVE DISEASES
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ES2525087T5 (es) 2000-05-10 2018-06-28 Novartis Ag Polvos basados en fosfolípidos para administración de fármacos
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
JP4745608B2 (ja) 2001-07-27 2011-08-10 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 電子伝達剤のリン酸誘導体を用いた皮膚治療
AUPR684801A0 (en) * 2001-08-06 2001-08-30 Vital Health Sciences Pty Ltd Supplement therapy
JP2005515969A (ja) * 2001-09-26 2005-06-02 バイタル ヘルス サイエンシズ プロプライアタリー リミティド ビタミン貯蔵の調節
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
NZ549567A (en) 2004-03-03 2009-10-30 Vital Health Sciences Pty Ltd Formulations comprising a tocopheryl phosphate tertiary amine alkaloid complex
CA2599612A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd. Use of phosphate derivatives of electron transfer agents for lowering increased circulating blood levels of a lipid
WO2006133506A1 (en) 2005-06-17 2006-12-21 Vital Health Sciences Pty Ltd A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
MX2012011355A (es) 2010-03-30 2012-11-30 Phosphagenics Ltd Parche de suministro transdermico.
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
CN104297412B (zh) * 2014-10-17 2015-12-02 徐州工程学院 一种蛋白粉新鲜度的测定方法
JP6882321B2 (ja) 2015-12-09 2021-06-02 フォスファージニクス リミテッド 医薬製剤
NZ754168A (en) 2016-12-21 2024-08-30 Avecho Biotechnology Ltd Process for phosphorylating a complex alcohol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219295A (ja) * 1983-05-30 1984-12-10 Senjiyu Seiyaku Kk リン酸ジエステルまたはその塩およびそれらの製造法
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
JPH0781138B2 (ja) * 1986-12-02 1995-08-30 株式会社資生堂 抗酸化剤
JP2546687B2 (ja) * 1987-09-11 1996-10-23 千寿製薬株式会社 リン酸ジエステルまたはその塩からなる抗酸化剤
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder

Also Published As

Publication number Publication date
DE69019111D1 (de) 1995-06-08
ES2071725T3 (es) 1995-07-01
EP0430045A3 (en) 1991-11-06
DE69019111T2 (de) 1995-08-31
KR910009272A (ko) 1991-06-28
CA2029420C (en) 2000-09-19
EP0430045A2 (en) 1991-06-05
JP2854631B2 (ja) 1999-02-03
CA2029420A1 (en) 1991-05-22
JPH03161444A (ja) 1991-07-11
EP0430045B1 (en) 1995-05-03
ATE121939T1 (de) 1995-05-15

Similar Documents

Publication Publication Date Title
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
PT83647A (en) Process for the preparation of novel pharmaceutical benzimidazole derivatives and of pharmaceutical compositions containing the same
PH25859A (en) Composition for treatment of ischemic disorder
ATE152352T1 (de) Pharmazeutische zusammensetzungen zur hemmung der maillardreaktion
EP0321968A3 (en) Compounds active on the cardiovascular system
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
IE890648L (en) 4,5,6,7-Tetrahydroisothiazolo (4,5-c)pyridine derivatives and isomere
EP0446921A3 (en) Optically active alkylene-dioxybenzene derivatives and their use in therapy
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
LT2199B (lt) 2-triazolidinono dariniu gavimo budas
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
AU2013888A (en) Uricosuric composition
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
EP0321967A3 (en) Compounds active on the cardiovascular system
TW360630B (en) A secoaporphine compounds on arrhythmia